Targeted PRP protocols address disc tears, joint pain, and spinal instability using precise diagnostic steps and injection techniques for long-term relief.
Platelet-Rich Plasma (PRP) is typically considered after conservative steroid treatment has failed to provide meaningful or lasting relief. The starting point is usually one or two low-dose, non-particulate steroid injections—specifically, 5 mg of Dexamethasone combined with 3 cc of buffered D5W (5% dextrose in water) and ½ cc of Lidocaine or Marcaine.
If symptoms include leg pain consistent with sciatica, a Transforaminal ESI (TFESI) is used first. If that injection provides less than 50% relief or relief lasting under 2 weeks, a Caudal ESI may be the next step.
PRP becomes the next consideration when those injections still fail to provide adequate relief. With continued research, PRP may soon move into first-line treatment status, replacing steroids entirely in many cases.
The PRP protocol is rooted in careful diagnostic steps and tailored treatment paths based on symptoms and response to earlier interventions. As clinical outcomes and research continue to support its use, PRP is moving closer to becoming the standard of care for a wide range of spinal pain conditions.
Read more from the series “Evidence for Platelet-Rich Plasma in Spine Care”:
Ready to schedule your first appointment?